Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

RXRα is crucial for proper immune response and links diet to immune function.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Lhx2 helps retinal cells respond to signals for eye development.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

The LTF gene may help predict and manage nonspecific orbital inflammation.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Finding functions for unknown GPCRs is hard but key for making new drugs.